Chris Hemsworth's new documentary, "A Road Trip to Remember," takes viewers on a motorbike adventure around Melbourne and Australia's Northern Territory. His costar and father, 71-year-old Craig ...

Norah O'Donnell is CBS News' senior correspondent and a 60 Minutes contributing correspondent. O'Donnell is also the host of CBS News 24/7's "Person to Person," where she brings interviews that go ...

Chat Generative Pretrained Transformer (ChatGPT) has emerged as a sophisticated artificial intelligence (AI) language model in healthcare. This narrative review examines ChatGPT's current applications ...

Washington — The Supreme Court on Tuesday grappled with a Colorado counselor's challenge to the state's ban on "conversion therapy" for minors. The case was brought by Kaley Chiles, who argued the ...

The Supreme Court heard arguments in a case that could strike down bans on so-called conversion therapy for children. Conversion therapy broadly refers to attempts to change a person’s sexual ...

The Supreme Court appeared receptive to a landmark challenge to a Colorado law banning "conversion therapy" for children questioning their sexuality or gender identity. More than half the states have ...

The US Supreme Court heard a case Tuesday that will determine whether a Colorado law that prohibits licensed mental health professionals from providing conversion “therapy” to minors is constitutional ...

Scientists report the first therapy to slow the deadly brain disease. A one-time gene therapy treatment has shown remarkable success in slowing the progression of Huntington's disease in a preliminary ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

An experimental gene therapy has become the first treatment to successfully slow the progression of Huntington’s disease. While the findings are still preliminary, the approach could be a major ...

An experimental gene therapy was found to slow the progression of Huntington’s disease in a “pivotal” Phase 1/2 study, according to drugmaker uniQure, marking a major step toward a potential first ...

Results from a three-year trial suggest an experimental gene therapy for Huntington's disease can slow the progression of the deadly condition by 75%. When you purchase through links on our site, we ...